JP2018501829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501829A5 JP2018501829A5 JP2017523772A JP2017523772A JP2018501829A5 JP 2018501829 A5 JP2018501829 A5 JP 2018501829A5 JP 2017523772 A JP2017523772 A JP 2017523772A JP 2017523772 A JP2017523772 A JP 2017523772A JP 2018501829 A5 JP2018501829 A5 JP 2018501829A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- light
- therapeutic solution
- therapeutic
- fiber optic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000243 solution Substances 0.000 claims description 86
- 230000001225 therapeutic Effects 0.000 claims description 59
- 239000000835 fiber Substances 0.000 claims description 25
- 239000003365 glass fiber Substances 0.000 claims description 16
- 230000002708 enhancing Effects 0.000 claims description 12
- 239000007800 oxidant agent Substances 0.000 claims description 12
- 230000001590 oxidative Effects 0.000 claims description 11
- 230000000844 anti-bacterial Effects 0.000 claims description 10
- 230000002195 synergetic Effects 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 230000003287 optical Effects 0.000 claims description 8
- 230000000845 anti-microbial Effects 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- 239000003595 mist Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 230000000813 microbial Effects 0.000 claims description 5
- 210000001519 tissues Anatomy 0.000 claims description 5
- 210000003371 Toes Anatomy 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 230000001678 irradiating Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 206010000496 Acne Diseases 0.000 claims description 2
- 229960003260 Chlorhexidine Drugs 0.000 claims description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N Ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 2
- 102000033147 ERVK-25 Human genes 0.000 claims description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000282412 Homo Species 0.000 claims description 2
- 102000016387 Pancreatic Elastase Human genes 0.000 claims description 2
- 108010067372 Pancreatic Elastase Proteins 0.000 claims description 2
- 108091005771 Peptidases Proteins 0.000 claims description 2
- 108010059820 Polygalacturonase Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 210000002832 Shoulder Anatomy 0.000 claims description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 2
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 claims description 2
- 230000001093 anti-cancer Effects 0.000 claims description 2
- 230000000118 anti-eoplastic Effects 0.000 claims description 2
- 230000003110 anti-inflammatory Effects 0.000 claims description 2
- 230000000840 anti-viral Effects 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000000812 cholinergic antagonist Substances 0.000 claims description 2
- 229960003405 ciprofloxacin Drugs 0.000 claims description 2
- 230000000249 desinfective Effects 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 125000003454 indenyl group Chemical class C1(C=CC2=CC=CC=C12)* 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 150000002497 iodine compounds Chemical class 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 230000002921 anti-spasmodic Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drugs Drugs 0.000 description 6
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
Description
本発明の1つの側面[1]では、装置は、ユーザーの組織に対して治療用溶液を保持するのに適している溶液リテーナ;光ファイバーケーブル;前記光ファイバーケーブルに連結し、所定波長の光を当該光ファイバーケーブルに提供する光源;及び、前記治療用溶液に前記光を照射する前記光ファイバーケーブルの光終端、を備える。また本発明は以下の態様であってもよい。
[2] 前記溶液は、初期の微生物有効性を有し、
前記光は、前記治療用溶液と相乗反応することにより、前記治療用溶液の抗菌効果を強化する、[1]の装置。
[3] 前記溶液は、初期の微生物有効性を有し、前記光は、前記治療用溶液と相乗反応することにより、前記溶液の抗菌効果を強化する、[1]の装置。
[4] 前記治療用溶液は過酸化水素であり、
前記光は、前記治療用溶液の抗菌効果を強化する相乗反応をもたらす、[1]の装置。
[5] 前記治療用溶液はキャリアーと結合される酸化剤であり、
前記光は、前記治療用溶液のニキビ治療効果を強化する相乗反応をもたらす、[1]の装置。
[6] 前記治療用溶液は抗新生物薬であり、
前記光は、前記治療用溶液の抗癌効果を強化する相乗反応をもたらす、[1]の装置。
[7] アプリケーションの間、前記治療用溶液を温めるために、前記溶液リテーナの内部を巻回する加熱要素を更に備える、請求項1の装置。
[8] 所定波長の前記光を提供する外部光源;
前記光源を前記光ファイバーケーブルと光学的に連結する光ファイバー連結ケーブル;及び
前記光源が着脱可能なように、前記光ファイバー連結ケーブルの上でプラグとかみ合う前記溶液リテーナのソケット、を更に備える、請求項1の装置。
[9] 前記溶液リテーナは、歯科用トレイの側の空洞で治療用溶液を保持する前記歯科用トレイを備え;
前記光ファイバーケーブルは、前記トレイ内で保持され;
前記組織は、前記ユーザーの歯であり;
前記トレイは、光照射された前記治療用溶液を歯に対して保持するように形づくられ;
前記装置は、前記光ファイバーケーブルから前記治療用溶液に光を出射する前記光ファイバーケーブル上の複数の光終端を更に含み、少なくとも1つの光終端が、各々の歯の2つの両側の各々に隣接するように、前記光終端は配置され、十分な量である、[1]の装置。
[10] 前記光ファイバーケーブルは、前記光が前記光ファイバーケーブルの側に向けられるように、一部の発光中心コアだけをカバーする外側シールドと、前記発光中心コアとを備える、[1]の装置。
[11] 前記溶液リテーナは、
人間用フルボディスーツ;
ミストとして前記治療用溶液を注入する注入チューブ;
ユーザーに対して前記ミストを循環させるスーツ内の領域;
スーツからミストを排出する排出チューブ;を備え、
前記光ファイバーケーブルは前記フルボディスーツの内面を包む、[1]の装置。
[12] 前記溶液リテーナは、
人間であるユーザーの腕を覆って、前記治療用溶液を提供するアーム・スリーブ;
人間であるユーザーの手又は手の一部を覆って、前記治療用溶液を提供する手袋;
人間であるユーザーの脚部又は脚部の一部を覆って、前記治療用溶液を提供する脚用ストッキング;
人間であるユーザーの1つ以上のつま先を覆って、前記治療用溶液を提供するつま先キャップ;
人間であるユーザーの頭部を覆って、前記治療用溶液を提供するヘルメット;及び
動物の背中、後ろ、肩、側部、及び、後部を覆うように形づくられていて、前記動物のまわりで閉じられるブランケットを取り外し可能に固定するための固定要素を具備するストラップを更に備えるブランケット、からなるグループから選ばれる衣服から成る、[1]の装置。
[13] 前記溶液リテーナは、
カテーテル・チューブの第1の端部において前記治療用溶液を受け取る前記カテーテル・チューブ;及び
前記ユーザーに前記治療用溶液を分配するための、前記第1の端部の反対側の前記カテーテル・チューブの第2の端部の近くのカテーテル・チューブ内のメッシュ;を備え、
前記光終端は、前記メッシュの近くの光ファイバーケーブル上に配置されている、[1]の装置。
In one aspect [1] of the present invention, the device is a solution retainer suitable for holding a therapeutic solution to a user's tissue; a fiber optic cable; and coupled to the fiber optic cable to transmit light of a predetermined wavelength. A light source provided to the optical fiber cable; and an optical terminal of the optical fiber cable for irradiating the therapeutic solution with the light. Moreover, the following aspects may be sufficient as this invention.
[2] The solution has an initial microbial effectiveness;
The device according to [1], wherein the light synergizes with the therapeutic solution to enhance the antibacterial effect of the therapeutic solution.
[3] The apparatus according to [1], wherein the solution has initial microbial effectiveness, and the light synergizes with the therapeutic solution to enhance the antibacterial effect of the solution.
[4] The therapeutic solution is hydrogen peroxide,
The device of [1], wherein the light causes a synergistic reaction that enhances the antibacterial effect of the therapeutic solution.
[5] The therapeutic solution is an oxidant combined with a carrier;
The device according to [1], wherein the light causes a synergistic reaction that enhances an acne treatment effect of the therapeutic solution.
[6] The therapeutic solution is an anti-neoplastic agent;
The device of [1], wherein the light causes a synergistic reaction that enhances an anticancer effect of the therapeutic solution.
[7] The apparatus of claim 1, further comprising a heating element that wraps around the interior of the solution retainer to warm the therapeutic solution during application.
[8] An external light source that provides the light having a predetermined wavelength;
An optical fiber connection cable for optically connecting the light source to the optical fiber cable; and
The apparatus of claim 1, further comprising a socket of the solution retainer that mates with a plug on the optical fiber connection cable so that the light source is removable.
[9] The solution retainer includes the dental tray that holds a therapeutic solution in a cavity on the side of the dental tray;
The fiber optic cable is held in the tray;
The tissue is the user's teeth;
The tray is shaped to hold the irradiated therapeutic solution against the teeth;
The apparatus further includes a plurality of light terminations on the fiber optic cable that emit light from the fiber optic cable to the therapeutic solution, such that at least one light termination is adjacent to each of the two sides of each tooth. In addition, the apparatus according to [1], wherein the optical terminal is disposed and has a sufficient amount.
[10] The apparatus according to [1], wherein the optical fiber cable includes an outer shield that covers only a part of the light emission center core and the light emission center core so that the light is directed toward the optical fiber cable.
[11] The solution retainer includes:
Full body suit for humans;
An injection tube for injecting the therapeutic solution as a mist;
The area in the suit where the mist is circulated to the user;
A discharge tube for discharging the mist from the suit;
The apparatus according to [1], wherein the optical fiber cable wraps an inner surface of the full body suit.
[12] The solution retainer includes:
An arm sleeve that covers the arm of a human user and provides the therapeutic solution;
A glove that covers a human user's hand or part of the hand and provides the therapeutic solution;
A leg stocking covering the leg or part of the leg of a human user to provide the therapeutic solution;
A toe cap covering one or more toes of a human user to provide the therapeutic solution;
A helmet that covers the head of a human user and provides the therapeutic solution; and
A blanket further comprising a strap shaped to cover the back, back, shoulders, sides, and rear of the animal, the strap comprising a securing element for removably securing the blanket that is closed around the animal; The apparatus of [1], comprising a garment selected from the group consisting of:
[13] The solution retainer includes:
The catheter tube receiving the therapeutic solution at a first end of the catheter tube; and
A mesh in a catheter tube near the second end of the catheter tube opposite the first end for dispensing the therapeutic solution to the user;
The apparatus according to [1], wherein the optical terminal is disposed on an optical fiber cable near the mesh.
本発明のもう1つの側面[14]では、製剤は、酸化剤を含む溶液;初期の治療的効果を有する治療用溶液;及び、前記酸化剤と相乗反応することにより前記溶液の前記初期の治療的効果を強化する所定周波数の光、を備える。また本発明は以下の態様であってもよい。
[15] 前記治療用溶液は、酸化剤と結合される目標化学物質を含み、結合溶液は、前記治療用溶液の抗菌効果、抗ウイルス効果、抗新生物効果を強化する光と相乗反応し;
前記目標化学物質は、
抗菌性の、殺菌性の、又は、消毒性の化合物;
クロルヘキシジンを含む抗菌化合物;
インデン派生物を含む非ステロイド性の抗炎症性化合物;
ヨウ素化合物;
腫瘍壊死因子(Tumor Necrosis Factor);
プロテアーゼ、ペクチナーゼ、又は、エラスターゼ化合物;
シプロフロキサシン;
鎮痙薬;及び
メチレンクロライド(methylene bicloride)、からなるグループから選ばれる、[14]の製剤。
In another aspect of the invention [14] , the formulation comprises a solution comprising an oxidant; a therapeutic solution having an initial therapeutic effect; and the initial treatment of the solution by synergistic reaction with the oxidant. Light of a predetermined frequency that enhances the optical effect. Moreover, the following aspects may be sufficient as this invention.
[15] The therapeutic solution includes a target chemical that is combined with an oxidant, and the binding solution synergizes with light to enhance the antibacterial, antiviral, and anti-neoplastic effects of the therapeutic solution;
The target chemical substance is
Antibacterial, bactericidal or disinfecting compounds;
Antimicrobial compounds including chlorhexidine;
Non-steroidal anti-inflammatory compounds including indene derivatives;
Iodine compounds;
Tumor Necrosis Factor;
A protease, pectinase or elastase compound;
Ciprofloxacin;
Antispasmodic drugs; and
[14] The preparation of [14], selected from the group consisting of methylene bicloride.
本発明の実施形態は、概して、薬に対する所定の周波数の光照射によって強化される効果を有する薬を提供する。 Embodiments of the present invention generally provide a drug that has an effect that is enhanced by light irradiation at a predetermined frequency on the drug.
装置の実施形態は、治療用溶液に特定の波長の光、例えば目的を持って選ばれた波長又は周波数のLED又はレーザーからの光を照射可能な発光光ファイバーケーブルを含んでもよい。カバーは、抗菌溶液を保持してもよい。実施形態は、発光光ファイバーケーブルの上に複数の光終端又は他の発光体を含んでもよい。それぞれの光終端は、光ファイバーケーブルに入り込み、終端の端から光を外へ出射し、それによって、治療用溶液に光を出射する。当該終端を加えたり、移動したりできるように、又は、個々のユーザーにフィットするように光終端の量と位置を測定可能なように、装置は調節可能であってもよい。それぞれの光終端が、例えば、扱われる組織の近い部分等、リテーナの範囲内のあらかじめ選択された位置に配置されるように、光終端は、カバーの内部、又は、表面に、位置してもよい。光ファイバーケーブルは、その長さに沿って間隔をあけられる発光体でくすんでいてもよく、その長さに沿って光を出射するために、少なくとも部分的に半透明であってもよい。ユーザーは、人間又は動物であってもよい。 Embodiments of the device, light of a specific wavelength in the treatment solution, for example an LED or laser or these optical wavelengths or frequencies selected with a purpose may include irradiating possible emission fiber optic cable. The cover may hold an antimicrobial solution. Embodiments may include multiple light terminations or other light emitters on the light emitting fiber optic cable. Each light termination enters the fiber optic cable and emits light out of the end of the termination, thereby emitting light to the therapeutic solution. The device may be adjustable so that the termination can be added and moved, or the amount and position of the optical termination can be measured to fit an individual user. The light terminations may also be located inside or on the surface of the cover so that each light termination is located at a preselected location within the retainer, for example, in the vicinity of the treated tissue. Good. The fiber optic cable may be dull with a light emitter spaced along its length, and may be at least partially translucent to emit light along its length. The user may be a human or an animal.
実施形態において、第1の反応は、例えば過酸化水素等の酸化剤と組み合わされた、例えば400−500ナノメートル等の特定の波長の光を含んでもよい。光プラス酸化剤は、それのみで治療であってもよい。第2の反応は、酸化剤と組み合わされ、更に相乗反応を経ている目標化学物質と組み合わされる特定の波長の光を含んでもよい。薬の実施形態は、光によって強化(light-enhanced)された治療的効果を持つ薬を提供するために、光によって強化された酸化剤と光によって強化された目標化学物質を含んでもよい。薬は、光源から光が照射される間、ユーザーと接触して保持される溶液であってもよく、又は、溶液は、提供前に、光によって強化されていてもよい。当該光は、薬又は溶液に同時に照射される2つの周波数を含んでいてもよく、又は、連続して(in series)、第1の周波数の光が照射され、次いで、第2の周波数の光が照射されてもよい。 In embodiments, the first reaction may include light of a particular wavelength, such as 400-500 nanometers, combined with an oxidant such as hydrogen peroxide. The light plus oxidant may be therapeutic alone. The second reaction may include a specific wavelength of light combined with the target chemical that is combined with the oxidant and undergoing a synergistic reaction. Drug embodiments may include a light-enhanced oxidant and a light-enhanced target chemical to provide a drug with a light-enhanced therapeutic effect. The drug may be a solution that is held in contact with the user while illuminated by light from the light source, or the solution may be enhanced by light prior to delivery. The light may include two frequencies that are simultaneously applied to the drug or solution, or in series, irradiated with light of a first frequency and then light of a second frequency . May be irradiated.
歯科.図1は、歯の装置10の実施形態を示す。発光光ファイバーケーブル12は、抗菌溶液14に対して、特定の波長の光、例えば目的を持って選ばれた波長又は周波数のLED又はレーザーからの光を照射してもよい。トレイ16は、抗菌溶液14を保持してもよい。実施形態は、発光光ファイバーケーブル12の上に、複数の光終端18又は他の発光体を含んでもよい。それぞれの光終端18は、光ファイバーケーブル12に入り込み、終端18の端から光を外へ出射し、それによって、抗菌溶液14に光を出射する。当該終端18を加えたり、移動したりできるように、又は、個々のユーザーにフィットするように光終端18の量と位置を測定可能なように、装置は調節可能であってもよい。それぞれの光終端18が、ユーザーの隣接した歯の間、又は、ユーザーの歯に隣接して配置されるように、光終端18は、トレイ16の内部に位置してもよい。光ファイバーケーブルは、その長さに沿って間隔をあけられる発光体でくすんでいてもよく、その長さに沿って光を出射するために、少なくとも部分的に半透明であってもよい。実施形態において、光ファイバーケーブル12は、光ファイバー連結ケーブル22によって、光源20に連結されてもよい。光源20を結合可能、且つ、使用後に取り外し可能なように、連結ケーブル22はトレイ16に入り込んでいてもよく、光ファイバー連結インターフェース24によって光学的に光ファイバーケーブル12に連結していてもよい。インターフェース24の実施形態は、光ファイバー連結ケーブル22を光ファイバーケーブル12に取り付ける開口をトレイ16の壁に含んでもよい。インターフェース24の他の実施形態は、光源を結合可能、且つ、使用後に取り外し可能なように、トレイ16の上に、連結ケーブル22の上でプラグとかみ合うソケットを含んでもよい。 Dentistry. FIG. 1 shows an embodiment of a dental device 10. Emitting fiber optic cable 12, to the antimicrobial solution 14, light of a specific wavelength, for example, the light from the LED or laser of wavelength or frequency selected with a purpose may be irradiated. The tray 16 may hold the antibacterial solution 14. Embodiments may include multiple light terminations 18 or other light emitters on the light emitting fiber optic cable 12. Each light termination 18 enters the optical fiber cable 12 and emits light outward from the end 18, thereby emitting light to the antimicrobial solution 14. The device may be adjustable so that the end 18 can be added and moved, or the amount and position of the light end 18 can be measured to fit an individual user. The light terminations 18 may be located inside the tray 16 such that each light termination 18 is positioned between or adjacent to the user's adjacent teeth. The fiber optic cable may be dull with a light emitter spaced along its length, and may be at least partially translucent to emit light along its length. In the embodiment, the optical fiber cable 12 may be connected to the light source 20 by the optical fiber connection cable 22. The connection cable 22 may enter the tray 16 and may be optically connected to the fiber optic cable 12 by the fiber optic connection interface 24 so that the light source 20 can be coupled and removed after use. Embodiments of the interface 24 may include an opening in the tray 16 wall that attaches the fiber optic connecting cable 22 to the fiber optic cable 12. Other embodiments of the interface 24 may include a socket on the tray 16 that mates with a plug on the connecting cable 22 so that the light source can be coupled and removed after use.
Claims (14)
光ファイバーケーブル、
前記光ファイバーケーブルに連結し、所定波長の光を前記光ファイバーケーブルに提供する光源、及び
前記治療用溶液に前記光を照射する光ファイバーケーブル上の光終端、
を備え、
前記治療用溶液は、初期の微生物有効性を有し、
前記光は、前記治療用溶液に対して、前記治療用溶液の前記初期の微生物有効性を強化する相乗反応を起こす、
装置。 A solution retainer, suitable for holding a therapeutic solution for the user's tissue,
Fiber optic cable,
A light source coupled to the fiber optic cable and providing light of a predetermined wavelength to the fiber optic cable; and a light termination on the fiber optic cable for irradiating the treatment solution with the light;
Equipped with a,
The therapeutic solution has an initial microbial effectiveness;
The light causes a synergistic reaction to the therapeutic solution that enhances the initial microbial effectiveness of the therapeutic solution;
apparatus.
前記光は、前記治療用溶液と相乗反応することにより、前記溶液の抗菌効果を強化する、請求項1に記載の装置。 The solution has an initial microbial effectiveness;
The device of claim 1, wherein the light synergizes with the therapeutic solution to enhance the antimicrobial effect of the solution.
前記光は、前記治療用溶液のニキビ治療効果を強化する相乗反応をもたらす、請求項1に記載の装置。 The therapeutic solution is an oxidant combined with a carrier;
The device of claim 1, wherein the light provides a synergistic response that enhances the acne treatment effect of the therapeutic solution.
前記光は、前記治療用溶液の抗癌効果を強化する相乗反応をもたらす、請求項1に記載の装置。 The therapeutic solution is an antineoplastic agent;
The device of claim 1, wherein the light provides a synergistic response that enhances the anti-cancer effect of the therapeutic solution.
前記光源を前記光ファイバーケーブルと光学的に連結する光ファイバー連結ケーブル;及び
前記光源が着脱可能なように、前記光ファイバー連結ケーブルの上でプラグとかみ合う前記溶液リテーナのソケット、を更に備える、請求項1の装置。 An external light source providing the light of a predetermined wavelength;
The optical fiber connection cable for optically connecting the light source to the optical fiber cable; and the socket of the solution retainer that engages with a plug on the optical fiber connection cable so that the light source is removable. apparatus.
前記光ファイバーケーブルは、前記トレイ内で保持され;
前記組織は、前記ユーザーの歯であり;
前記トレイは、光照射された前記治療用溶液を歯に対して保持するように形づくられ;
前記装置は、前記光ファイバーケーブルから前記治療用溶液に光を出射する前記光ファイバーケーブル上の複数の光終端を更に含み、少なくとも1つの光終端が、各々の歯の2つの両側の各々に隣接するように、前記光終端は配置される、請求項1に記載の装置。 The solution retainer comprises the dental tray for holding a therapeutic solution in a cavity on the side of the dental tray;
The fiber optic cable is held in the tray;
The tissue is the user's teeth;
The tray is shaped to hold the irradiated therapeutic solution against the teeth;
The apparatus further includes a plurality of light terminations on the fiber optic cable that emit light from the fiber optic cable to the therapeutic solution, such that at least one light termination is adjacent to each of the two sides of each tooth. in the optical terminal is Ru are arranged, according to claim 1.
人間用フルボディスーツ;
ミストとして前記治療用溶液を注入する注入チューブ;
ユーザーに対して前記ミストを循環させるスーツ内の領域;
スーツからミストを排出する排出チューブ;を備え、
前記光ファイバーケーブルは前記フルボディスーツの内面を包む、請求項1に記載の装置。 The solution retainer is
Full body suit for humans;
An injection tube for injecting the therapeutic solution as a mist;
The area in the suit where the mist is circulated to the user;
A discharge tube for discharging the mist from the suit;
The apparatus of claim 1, wherein the fiber optic cable wraps the inner surface of the full body suit.
人間であるユーザーの腕を覆って、前記治療用溶液を提供するアーム・スリーブ;
人間であるユーザーの手又は手の一部を覆って、前記治療用溶液を提供する手袋;
人間であるユーザーの脚部又は脚部の一部を覆って、前記治療用溶液を提供する脚用ストッキング;
人間であるユーザーの1つ以上のつま先を覆って、前記治療用溶液を提供するつま先キャップ;
人間であるユーザーの頭部を覆って、前記治療用溶液を提供するヘルメット;及び
動物の背中、後ろ、肩、側部、及び、後部を覆うように形づくられていて、前記動物のまわりで閉じられるブランケットを取り外し可能に固定するための固定要素を具備するストラップを更に備えるブランケット、からなるグループから選ばれる衣服から成る、請求項1に記載の装置。 The solution retainer is
An arm sleeve that covers the arm of a human user and provides the therapeutic solution;
A glove that covers a human user's hand or part of the hand and provides the therapeutic solution;
A leg stocking covering the leg or part of the leg of a human user to provide the therapeutic solution;
A toe cap covering one or more toes of a human user to provide the therapeutic solution;
A helmet that covers the human user's head and provides the therapeutic solution; and is shaped to cover the back, back, shoulders, sides, and back of the animal and closes around the animal The apparatus of claim 1, comprising a garment selected from the group consisting of: a blanket further comprising a strap with a securing element for removably securing the blanket to be removed.
カテーテル・チューブの第1の端部において前記治療用溶液を受け取る前記カテーテル・チューブ;及び
前記ユーザーに前記治療用溶液を分配するための前記第1の端部の反対側の前記カテーテル・チューブの第2の端部の近くのカテーテル・チューブ内のメッシュ;を備え、
前記光終端は、前記メッシュの近くの光ファイバーケーブル上に配置されている、請求項1に記載の装置。 The solution retainer is
The catheter tube receiving the therapeutic solution at a first end of the catheter tube; opposite the first end before Symbol for dispensing the therapeutic solution and the user of the catheter tube A mesh in the catheter tube near the second end;
The apparatus of claim 1, wherein the optical termination is disposed on a fiber optic cable near the mesh.
所定周波数の光が前記酸化剤に対して相乗反応を起こすことにより前記治療用溶液の前記初期の治療的効果が強化される、製剤。 Consisting of a therapeutic solution containing an oxidizing agent, said therapeutic solution having an initial therapeutic effect;
A formulation wherein the initial therapeutic effect of the therapeutic solution is enhanced by a synergistic reaction of light of a predetermined frequency to the oxidant .
前記目標化学物質は、
抗菌性の、殺菌性の、又は、消毒性の化合物;
クロルヘキシジンを含む抗菌化合物;
インデン派生物を含む非ステロイド性の抗炎症性化合物;
ヨウ素化合物;
腫瘍壊死因子(Tumor Necrosis Factor);
プロテアーゼ、ペクチナーゼ、又は、エラスターゼ化合物;
シプロフロキサシン;
鎮痙薬;及び
メチレンクロライド(methylene bicloride)、からなるグループから選ばれる、請求項13に記載の製剤。 The therapeutic solution includes a target chemical coupled with an oxidant, and the binding solution synergizes with light to enhance the antibacterial, antiviral, anti-neoplastic effects of the therapeutic solution;
The target chemical substance is
Antibacterial, bactericidal or disinfecting compounds;
Antimicrobial compounds including chlorhexidine;
Non-steroidal anti-inflammatory compounds including indene derivatives;
Iodine compounds;
Tumor Necrosis Factor;
A protease, pectinase or elastase compound;
Ciprofloxacin;
14. A formulation according to claim 13 , selected from the group consisting of an antispasmodic; and methylene bicloride.
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462026498P | 2014-07-18 | 2014-07-18 | |
US62/026,498 | 2014-07-18 | ||
US14/497,269 | 2014-09-24 | ||
US14/497,269 US9579177B2 (en) | 2014-07-18 | 2014-09-25 | Dental and medical devices with light source and antimicrobial solution |
US14/536,633 | 2014-11-09 | ||
US14/536,633 US9504848B2 (en) | 2014-07-18 | 2014-11-09 | Medical devices with a light source and antimicrobial solution |
US14/583,580 | 2014-12-26 | ||
US14/583,580 US9931189B2 (en) | 2014-07-18 | 2014-12-26 | Veterinary devices with a light source and antimicrobial solution |
US14/630,513 US9700735B2 (en) | 2014-07-18 | 2015-02-24 | Medical and veterinary applications of light to antimicrobial and antineoplastic chemicals |
US14/630,513 | 2015-02-24 | ||
US14/638,902 | 2015-03-04 | ||
US14/638,902 US10016456B2 (en) | 2014-07-18 | 2015-03-04 | Methods for treating acne vulgaris |
US14/697,579 US20160015745A1 (en) | 2014-07-18 | 2015-04-27 | Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light |
US14/697,579 | 2015-04-27 | ||
PCT/US2015/039292 WO2016010765A1 (en) | 2014-07-18 | 2015-07-07 | Medical and veterinary applications of light to therapeutic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018501829A JP2018501829A (en) | 2018-01-25 |
JP2018501829A5 true JP2018501829A5 (en) | 2018-05-24 |
Family
ID=55079906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017523772A Pending JP2018501829A (en) | 2014-07-18 | 2015-07-07 | Medical and veterinary light irradiation for therapeutic compounds |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3169400A4 (en) |
JP (1) | JP2018501829A (en) |
KR (1) | KR20170019383A (en) |
CN (1) | CN106659902A (en) |
AU (1) | AU2015290092B2 (en) |
CA (2) | CA2954886C (en) |
WO (1) | WO2016010765A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108853750B (en) * | 2018-07-16 | 2020-03-20 | 北京大学口腔医学院 | Wearable phototherapy equipment |
CN109009549A (en) * | 2018-08-20 | 2018-12-18 | 中国人民解放军军事科学院军事医学研究院 | Record the device of animal pharmaceuticals Addictive Behaviors and related brain areas nervous activity rule |
DE102020111257A1 (en) | 2020-04-24 | 2021-10-28 | Jessika Kähler | Arrangement for the photobiomodulation of a living being |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4898439A (en) * | 1988-02-10 | 1990-02-06 | Kei Mori | Light radiation device for use in medical treatment |
WO1998006456A1 (en) * | 1996-08-08 | 1998-02-19 | Light Sciences Limited Partnership | Method and apparatus to treat gingival and periodontal disease |
US6254391B1 (en) * | 1997-11-22 | 2001-07-03 | Daniel Henry Darnell | Device for heating the teeth and uses therefor |
US8241035B2 (en) * | 2005-05-25 | 2012-08-14 | Biolase, Inc. | Device having activated textured surfaces for treating oral tissue |
AU2002226726B8 (en) * | 2001-01-29 | 2007-02-08 | Japan Industrial Technology Association | Tooth bleaching agents and method of bleaching teeth |
EP1542556B1 (en) * | 2002-01-08 | 2011-09-21 | Bernard Technologies, Inc. | Antimicrobial body covering articles |
US6893259B1 (en) * | 2004-03-08 | 2005-05-17 | Igor Reizenson | Oral hygiene device and method of use therefor |
ES2432140T3 (en) * | 2004-08-06 | 2013-11-29 | Syneron Beauty Ltd. | Therapy device |
GB0423332D0 (en) * | 2004-10-21 | 2004-11-24 | Dezac Ltd | Tooth whitening apparatus and methods |
JP2006271831A (en) * | 2005-03-30 | 2006-10-12 | Terumo Corp | Medical treatment device and its usage |
WO2007025244A2 (en) * | 2005-08-25 | 2007-03-01 | Houle Philip R | Treatment systems for delivery of sensitizer solutions |
US8057464B2 (en) * | 2006-05-03 | 2011-11-15 | Light Sciences Oncology, Inc. | Light transmission system for photoreactive therapy |
EA024725B1 (en) * | 2008-11-07 | 2016-10-31 | Клокс Текнолоджиз Инк. | Oxidative photoactivated skin rejuvenation composition comprising hyaluronic acid, glucosamine, or allantoin |
WO2010085651A1 (en) * | 2009-01-23 | 2010-07-29 | The Penn State Research Foundation | In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles |
US8877125B2 (en) * | 2009-06-30 | 2014-11-04 | 3M Innovative Properties Company | Light-activated antimicrobial articles and methods of use |
KR20130020883A (en) * | 2010-03-11 | 2013-03-04 | 메르크 파텐트 게엠베하 | Fibers in therapy and cosmetics |
US8591229B2 (en) * | 2010-12-16 | 2013-11-26 | Duane C. Keller | Devices and methods for creating a positive pressure environment for treatment of oral biofilms associated with periodontal disease |
US20150072302A1 (en) * | 2013-04-19 | 2015-03-12 | Jasibo, LLC. | Light activated tooth whitening composition |
US20150045720A1 (en) * | 2013-08-08 | 2015-02-12 | A-Z Ltd. | Method for treating local infection |
-
2015
- 2015-07-07 KR KR1020167036689A patent/KR20170019383A/en not_active Application Discontinuation
- 2015-07-07 JP JP2017523772A patent/JP2018501829A/en active Pending
- 2015-07-07 CA CA2954886A patent/CA2954886C/en active Active
- 2015-07-07 CA CA2985090A patent/CA2985090C/en active Active
- 2015-07-07 AU AU2015290092A patent/AU2015290092B2/en active Active
- 2015-07-07 WO PCT/US2015/039292 patent/WO2016010765A1/en active Application Filing
- 2015-07-07 EP EP15821889.1A patent/EP3169400A4/en not_active Withdrawn
- 2015-07-07 CN CN201580038475.2A patent/CN106659902A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7544204B2 (en) | Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract | |
Plotino et al. | Photodynamic therapy in endodontics | |
US7435252B2 (en) | Control of microorganisms in the sino-nasal tract | |
CN102271760B (en) | Radiological unit | |
KR102057349B1 (en) | Irradiation apparatus | |
JP2018108442A (en) | Phototherapeutic devices and methods | |
US20180036554A1 (en) | Device and Methods For Use In Removal Of Bio-Film And Treatment Of Halitosis | |
JP2018501829A5 (en) | ||
US9579177B2 (en) | Dental and medical devices with light source and antimicrobial solution | |
KR20140132119A (en) | Athletes foot treatment equipment with sterilization and heating function | |
US10136963B2 (en) | System and method for introducing photosensitive dyes via an insert into a root canal in a tooth, method for producing said dye impregnated insert and method of using said dye-impregnated insert | |
EP2424536A4 (en) | Novel photosensitizer formulations for oral administration | |
Hopp et al. | Photodynamic therapies–blue versus green | |
DE102021104921B4 (en) | Elongated lighting means with at least one light source emitting directed light as a mobile disinfection device | |
CA2954886C (en) | Medical and veterinary applications of light to therapeutic compounds | |
US20220125922A1 (en) | Photosensitive Dyes and Method of Using Said Dyes | |
US20210186672A1 (en) | Apparatus and method for applying medicants | |
EP3875146A1 (en) | Lighting means, in particular for the reduction of germs, with preferably at least two light sources, and method for using the lighting means as a mobile disinfectant | |
AT17416U1 (en) | Lighting means, in particular for reducing germs, preferably with at least two light sources, and methods for using the lighting means as a mobile disinfection device | |
US20160354407A1 (en) | Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light | |
CN214435867U (en) | Stomatitis therapeutic instrument | |
RU2595792C2 (en) | Device for use in antimicrobial photodynamic therapy | |
US20210353754A1 (en) | Pigment for antimicrobial photodynamic therapy | |
EP4196211A1 (en) | Light therapy device | |
TWM357961U (en) | Light-guided engage apparatus of occludator |